BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 11248018)

  • 21. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
    Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
    J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into prion structure and toxicity.
    Harris DA; True HL
    Neuron; 2006 May; 50(3):353-7. PubMed ID: 16675391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.
    Swietnicki W; Morillas M; Chen SG; Gambetti P; Surewicz WK
    Biochemistry; 2000 Jan; 39(2):424-31. PubMed ID: 10631004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of rafts in the fibrillization and aggregation of prions.
    Pinheiro TJ
    Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and dynamic properties of the human prion protein.
    Chen W; van der Kamp MW; Daggett V
    Biophys J; 2014 Mar; 106(5):1152-63. PubMed ID: 24606939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Residue-specific mobility changes in soluble oligomers of the prion protein define regions involved in aggregation.
    Glaves JP; Ladner-Keay CL; Bjorndahl TC; Wishart DS; Sykes BD
    Biochim Biophys Acta Proteins Proteom; 2018 Sep; 1866(9):982-988. PubMed ID: 29935976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prion protein and lipid rafts.
    Taylor DR; Hooper NM
    Mol Membr Biol; 2006; 23(1):89-99. PubMed ID: 16611584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detailed computational analysis revealed mutation V210I on PrP induced conformational conversion on β2-α2 loop and α2-α3.
    Chandrasekaran P; Rajasekaran R
    Mol Biosyst; 2016 Oct; 12(10):3223-33. PubMed ID: 27523988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of prion proteins to lipid membranes.
    Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
    Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural insights into the interaction between prion protein and nucleic acid.
    Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
    Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assembly of natural and recombinant prion protein into fibrils.
    Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
    Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pH-triggered conversion of the PrP(c) to PrP(sc.).
    Zhou GP; Huang RB
    Curr Top Med Chem; 2013; 13(10):1152-63. PubMed ID: 23647538
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different antigenicities of the N-terminal region of cellular and scrapie prion proteins.
    Ushiki-Kaku Y; Iwamaru Y; Masujin K; Imamura M; Itohara S; Ogawa-Goto K; Hattori S; Yokoyama T
    Microbiol Immunol; 2013 Nov; 57(11):792-6. PubMed ID: 24117858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH-dependent prion protein conformation in classical Creutzfeldt-Jakob disease.
    Zanusso G; Farinazzo A; Fiorini M; Gelati M; Castagna A; Righetti PG; Rizzuto N; Monaco S
    J Biol Chem; 2001 Nov; 276(44):40377-80. PubMed ID: 11682490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into Mechanisms of Transmission and Pathogenesis from Transgenic Mouse Models of Prion Diseases.
    Moreno JA; Telling GC
    Methods Mol Biol; 2017; 1658():219-252. PubMed ID: 28861793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Scrapie prions: a three-dimensional model of an infectious fragment.
    Huang Z; Prusiner SB; Cohen FE
    Fold Des; 1996; 1(1):13-9. PubMed ID: 9079359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rare large scale subdomain motions in prion protein can initiate aggregation.
    Schwarzinger S; Horn AH; Ziegler J; Sticht H
    J Biomol Struct Dyn; 2006 Jun; 23(6):581-90. PubMed ID: 16615804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immobilized prion protein undergoes spontaneous rearrangement to a conformation having features in common with the infectious form.
    Leclerc E; Peretz D; Ball H; Sakurai H; Legname G; Serban A; Prusiner SB; Burton DR; Williamson RA
    EMBO J; 2001 Apr; 20(7):1547-54. PubMed ID: 11285219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detailed biophysical characterization of the acid-induced PrP(c) to PrP(β) conversion process.
    Bjorndahl TC; Zhou GP; Liu X; Perez-Pineiro R; Semenchenko V; Saleem F; Acharya S; Bujold A; Sobsey CA; Wishart DS
    Biochemistry; 2011 Feb; 50(7):1162-73. PubMed ID: 21189021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diverse effects on the native β-sheet of the human prion protein due to disease-associated mutations.
    Chen W; van der Kamp MW; Daggett V
    Biochemistry; 2010 Nov; 49(45):9874-81. PubMed ID: 20949975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.